Share
Hybrid Cardiac Imaging for Clinical Decision-Making: From Diagnosis to Prognosis
Nudi, Francesco ; Schillaci, Orazio ; Biondi-Zoccai, Giuseppe (Author)
·
Springer
· Paperback
Hybrid Cardiac Imaging for Clinical Decision-Making: From Diagnosis to Prognosis - Nudi, Francesco ; Schillaci, Orazio ; Biondi-Zoccai, Giuseppe
£ 128.56
£ 142.84
You save: £ 14.28
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My WishlistsIt will be shipped from our warehouse between
Wednesday, May 29 and
Monday, June 03.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "Hybrid Cardiac Imaging for Clinical Decision-Making: From Diagnosis to Prognosis"
Performing any diagnostic test in medicine is always a matter of trying to get the condition of the patient diagnosed properly with the least effort, exposure, discomfort and at the same time with the lowest possible error probability.Pre-test probability is helpful but often imprecise, effectively overestimating the patient's risk profile. In a broader prevention objective, the phases of a disease, its onset, progression, and complications must be taken into account. The negative predictive value, which is so important, has in turn its main limitation in identifying the healthy patient, that is, the one who does not belong to any cluster of patients in which we would act in terms of prevention. In coronary syndromes, the goal is instead to evaluate coronary heart disease, from mild to more extensive and significant forms. For this purpose, it is necessary to use parameters that investigate different and complementary aspects: stenosis, ischemia, the morphology ofthe atherosclerotic plaque, metabolic processes, in particular vitality and apoptosis, the presence of inflammatory processes. The possibility, already present thanks to Hybrid Imaging, of 'joining' exams that study different aspects, will allow the patient to be increasingly characterized not only from a diagnostic point of view but also from a prognostic and personalized therapeutic choice.
